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Abstract
Complex disease mapping usually involves a combination of linkage and association techniques.
Linkage analysis can scan the entire genome in a few hundred tests. Association tests may involve
an even greater number of tests. However, association tests can localize the susceptibility genes
more accurately. Using a recently developed combined linkage and association strategy, we
analyzed a subset of the Collaborative Study on the Genetics of Alcoholism (COGA) data for the
Genetic Analysis Workshop 14 (GAW14). In this analysis, we first employed linkage analysis based
on frailty models that take into account age of onset information to establish which regions along
the chromosome are likely to harbor disease susceptibility genes for alcohol dependence. Second,
we used an association analysis by exploiting linkage disequilibrium to narrow down the peak
regions. We also compare the methods with mean identity-by-descent tests and transmission/
disequilibrium tests that do not use age of onset information.
Background
The Collaborative Study on the Genetics of Alcoholism
(COGA) is a large, multi-site genetic study to identify sus-
ceptibility genes for alcohol dependence and related phe-
notypes [1]. The COGA data have been analyzed using
nonparametric sib-pair methods with the two-point link-
age program and multipoint linkage program for affected
sib pairs [2]. Linkage signals were revealed on chromo-
somes 1, 2, 4, and 7.
Age of onset data are often collected in studies designed to
map a complex disease. If age at onset is genetically medi-
ated, it may carry useful linkage information. Genetic
analysis that incorporates variable age of onset may
improve the ability to map genes for complex diseases. In
this report, we analyzed the COGA data using genetic
methods based on additive genetic gamma frailty models
to account for age of onset or covariate information [3,4].
Methods
Consider a sibship with n sibs. Let Tj be the random vari-
able of age at disease onset for the jth sib. Let (tj,δj) be the
observed data where tj is the observed age at onset if δj = 1,
and age at censoring if δj = 0. Consider a marker locus d in
the test chromosomal region. We assume that the hazard
function of developing disease for the jth individuals at age
tj is modelled by the proportional hazards model with
random effect Zj,
λj(tj|Zj) = λ0(tj)exp(Xjβ)Zj, for j = 1, 2, ..., n,
where λ0(t) is the unspecified baseline hazard function,
and Xj is a vector of observed covariates for the jth sib and
β is a vector of regression parameters associated with the
covariates. Zj is the unobserved genetic frailty. The genetic
frailty is defined as the following
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where Vd = (v1, v2, ..., v2n - 1, v2n) is the inheritance vector
[5] of a sibship at locus d, v2j - 1 = 1 or 2, and v2j = 3 or 4 to
indicate the origins of the inherited alleles for j = 1, 2, ...,
n. Ud1 and Ud2 represent the genetic frailties due to part of
the genome on the two chromosomes of the father at
locus d. Ud3 and Ud4 represent the same, though for the
mother. The random frailty term, Up, takes into account
possible genetic contributions to shared familial effects.
Gamma distributions were used to model the frailties and
retrospective likelihood ratio tests were constructed for
linkage analysis [3]. After linkage evidence is established
by the linkage analysis [3], we used an association test in
the presence of linkage as proposed by Zhong and Li [4]
that examines the putative association between the dis-
ease and the testing allele at a candidate chromosomal
locus in the linked region. Because we use age-at-onset as
the outcome, the association test is based on the propor-
tional hazards model.
The dataset includes a total of 143 nuclear and multigen-
erational families with 1,614 individuals. There are two
kinds of diagnostic definitions of alcohol dependence,
labelled in the data set as ALDX1 and ALDX2. ALDX1
alcohol-dependent subjects were defined as those individ-
uals who met both the DSM-III-R (Diagnostic and Statis-
tical Manual of the American Psychiatric Association-
Revised) criteria for alcohol dependence and the Feighner
criteria for alcoholism. ALDX2 alcohol-dependent sub-
jects were defined as those who met the DSM-IV criteria.
Both ALDX1 and ALDX2 alcohol dependence phenotypes
are coded in four levels: pure unaffected, never drank,
unaffected with some symptoms, and affected. We com-
bined the first three codings as unaffected. We extracted
genotyped affected sib pairs with their parents from each
pedigree to ensure independence between nuclear fami-
lies. This yielded 142 affected sib pairs with their parents
for a total of 568 individuals for the ALDX1 phenotype for
alcoholism. For the ALDX2 phenotype, this yielded 117
affected sib pairs with their parents for a total of 468 indi-
viduals. We utilized MAPMAKER/SIBS linkage program
ZU U U jd v d v p jj =+ +
− 21 2 ,
Table 1: Table of linkage results
Sex Sex + Smoking
Chr Markers Position(cM) P-value Markers Position(cM) P-value
ALDX1
2 D2S1329 4.9 0.0098 D2S1319 4.9 0.008
2 D2S1790 114.2 0.001
2 D2S2370 184.3 0.006
2 D2S1323 251.9 0.002
3 D3S2398 216.5 0.006
4 D4S1651 110.3 0.003 D4S1651 110.3 0.003
6 GATA165G02 160.4 0.003 GATA165G02 160.4 0.003
7 D7S490 145.5 0.004 D7S490 145.5 0.0003
9 DBH.PCR2.1 165.5 0.0007
10 D10S1213 134.1 0.005
12 D12S390 67.9 0.007 D12S390 67.9 0.007
12 D12S2078 156.8 0.003 D12S2078 156.8 0.003
ALDX2
2 D2S1328 147.6 0.002 D2S1328 147.6 0.002
3 D3S2398 216.5 0.007
4 GABRB1 51.4 0.0007 GABRB1 51.4 0.0007
5 D5S1473 34 0.003
6 D6S1007 168.6 0.009
7 D7S1799 127.7 0.003 D7S1799 127.7 0.002
8 D8S1145 13.6 0.005 D8S1145 13.6 0.005
9 DBH.PCR2.1 165.5 0.001
12 D12S390 67.9 0.00004
13 D13S325 34.1 0.006
15 D15S816 122.6 0.006
16 D16S423 8.2 0.004
20 D20S94 80.9 0.002 D20S94 80.9 0.001
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[6] to estimate the full multipoint probability of each pair
of selected sibs sharing 0, 1, or 2 alleles identical by
descent (IBD) on each chromosome. We obtained the
Kaplan-Meier curves as the approximation to the baseline
functions using the available age-of-onset data from all of
the founders in the full dataset (287 for ALDX1 and 289
for ALDX2). The founders are individuals who do not
have parents in pedigree and are considered as random
subjects from the general population. The Kaplan-Meier
survival curves for females and males (figures not shown
here) indicate strong evidence of sex differences in ages of
onset distributions. Alcohol dependence is more com-
mon in males than females. The Kaplan-Meier survival
curves for smokers and nonsmokers (figures not shown
here) also indicate distributional differences between
smokers and nonsmokers.
For each of the two disease classifications, ALDX1 and
ALDX2, we first performed linkage analysis over the
whole genome, excluding the sex chromosome, using the
methods of Li and Zhong [3], adjusting sex and smoking
status as the covariates as well as the mean IBD test to ana-
lyze the microsatellite markers on each chromosome for
linkage. The mean IBD test determines whether affected
sib pairs share alleles at a specific marker more than the
Mendelian expectation under no linkage. After the linkage
evidence (p-value < 0.01) to some candidate genes is
established, we further applied the association method [4]
as well as the transmission/disequilibrium tests [7] to sin-
gle-nucleotide polymorphism (SNP) markers within the
peak regions.
Results
A preliminary multipoint genome scan using mean IBD
tests (figures not shown here) indicated some evidence of
linkage to ALDX1 in the regions around 145 cM of chro-
mosome 7 (p-value of 0.006), 161 cM of chromosome 6
(p-value of 0.008), and 157 cM of chromosome 12 (p-
value of 0.016). Evidence of linkage to ALDX2 was found
in the regions around 128 cM of chromosome 7 (p-value
of 0.0086), 14 cM of chromosome 8 (p-value of 0.0196),
169 cM of chromosome 6 (p-value of 0.021), 5 cM of
chromosome 2 (p-value of 0.041), and 148 cM of chro-
mosome 2 (p-value of 0.049).
Table 1 lists the names and the map positions in centi-
morgans of the markers near those peaks with p-values
less than 0.01 for genome scans using frailty models for
linkage incorporating gender as a covariate or gender and
smoking status as covariates for both ALDX1 and ALDX2.
Frailty models identified the regions with evidence of
linkage by the mean IBD tests, but with stronger signals,
and also revealed some new regions with significant evi-
dence of linkage. Adjusting for gender and smoking status
as covariates, the strongest evidence of linkage to ALDX1
was achieved on a region on chromosome 7 (Table 1).
Some evidence of linkage to ALDX2 was also found close
to that region. The strongest evidence of linkage to ALDX2
was obtained on a region on chromosome 12. The same
region was also found with some evidence of linkage to
ALDX1. Figure 1 displays the multipoint linkage scans
over chromosome 7 for ALDX1 and chromosome 12 for
ALDX2, adjusting gender and smoking status as covari-
ates.
For the association tests in the presence of linkage, we
present here only the SNPs within a 10-cM vicinity of the
two linkage peaks with smallest p-values under each of
disease criteria. For ALDX2, evidence of association at a
0.001 significant level using frailty models adjusting gen-
der and smoking status as covariates was found for SNPs
rs273954 and rs700273 on chromosome 7, and rs710411
on chromosome 9 and ALDX1, and between rs1978161,
rs1565933, rs1867299, rs2279400, rs1848125, rs1224438,
rs1495042, rs965125, and rs1444588 on chromosome 12,
and rs1039559 on chromosome 4. As a comparison, for
ALDX1, evidence of association at a 0.05 level using trans-
mission/disequilibrium test on trio (parents and one
affected sib) data was found between rs273954  and
rs727714  on chromosome 7; for ALDX2, evidence was
found for rs12142 and rs951149 on chromosome 4, and
rs1705748,  rs1705772,  rs1843910,  rs1846629, and
rs1820545 on chromosome 12.
Discussion
Although the markers identified under the two criteria,
ALDX1 and ALDX2, are not entirely the same, several
The multipoint linkage scans over chromosome 7 for ALDX1  and chromosome 12 for ALDX2, adjusting gender and smok- ing status as covariates Figure 1
The multipoint linkage scans over chromosome 7 for 
ALDX1 and chromosome 12 for ALDX2, adjusting 
gender and smoking status as covariates. The dashed 
horizontal lines refer to the negative of the natural logarithm 
of 0.001 (i.e., -log(0.001)) corresponding to the significance 
level of 0.001.
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common regions were identified. The similarity of the
regions supports some common genetic bases for ALDX1
and ALDX2, whereas the differences in the identified
regions underscore the importance of using different phe-
notypes. As studied in [3,4], the methods using frailty
models have correct type I error rates. The methods using
frailty models incorporate age at onset and covariate fac-
tors and can increase the power of detecting linkage evi-
dence over the traditional methods such as mean IBD test,
which does not make use of age at onset information
(Table 1). It is also interesting to note that the inclusion of
smoking as a covariate in the linkage analysis resulted in
more candidate genes with significant linkage evidence.
We should note that the p-values reported here are not
corrected for multiple comparisons.
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